In a case report to be published in the June issue of the Journal of Clinical Endocrinology & Metabolism , the authors reported healing after bringing this 63 year old female patient's vitamin D level back into the normal range and then offering her teriparatide, the daily injectable recombinant parathyroid hormone, for 16 months. Now, don't get me wrong. I'm not recommending that you start teriparatide based upon one patient's experience. But if you (or your patient) find yourself in a similar situation, consider looking at the study in detail. |
Write a comment:
|